加拿大及各省官方疫情信息网站
- 主题发起人 Riven
- 开始时间
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
安省报告第一例与AZ疫苗相关的血栓死亡病例。
死亡的男子40岁以上，4月底接种的AZ疫苗。他几周后死于疫苗引起的免疫性血小板减少症。
安省将近一百万人接种了AZ疫苗，共发生13例疫苗诱导的血小板减少症。AZ疫苗已于5月11日停止。
卫生官说：“与这种疫苗相关的风险很少，但确实存在。”
Nearly one million people in Ontario aged 40 and older have received the AstraZeneca vaccine. The province suspended the use of the vaccine in first doses on May 11, but has approved it for second doses for those who’ve already received it. There have been 13 cases of VIIT in the province so far, Yaffe said.
“The risks associated with this vaccine are rare, but they are real,” Yaffe said.
But she also said that those who received a first dose of AstraZeneca made the right choice. Experts maintain the blood-clotting syndrome associated with the AstraZeneca shot is exceedingly rare and treatable in most cases.
“I want to take this opportunity to reiterate that those who received AstraZeneca vaccine should feel very confident in their decision,” she said.
死亡的男子40岁以上，4月底接种的AZ疫苗。他几周后死于疫苗引起的免疫性血小板减少症。
安省将近一百万人接种了AZ疫苗，共发生13例疫苗诱导的血小板减少症。AZ疫苗已于5月11日停止。
卫生官说：“与这种疫苗相关的风险很少，但确实存在。”
COVID-19: Decision on Ontario school year coming 'soon'; Province reports 1st death from blood clot linked to AstraZeneca vaccine
Ontario also reported its first death associated with a rare blood clotting disorder linked to the Oxford-AstraZeneca vaccine. The man was in his 40s and received his vaccine at the end of April. He died a few weeks later of vaccine-induced immune thrombotic thrombocytopenia, Ontario’s associate medical officer of health, Dr. Barbara Yaffe, confirmed Tuesday.Nearly one million people in Ontario aged 40 and older have received the AstraZeneca vaccine. The province suspended the use of the vaccine in first doses on May 11, but has approved it for second doses for those who’ve already received it. There have been 13 cases of VIIT in the province so far, Yaffe said.
“The risks associated with this vaccine are rare, but they are real,” Yaffe said.
But she also said that those who received a first dose of AstraZeneca made the right choice. Experts maintain the blood-clotting syndrome associated with the AstraZeneca shot is exceedingly rare and treatable in most cases.
“I want to take this opportunity to reiterate that those who received AstraZeneca vaccine should feel very confident in their decision,” she said.
COVID-19: Decision on Ontario school year coming 'soon'; Province reports 1st death from blood clot linked to AstraZeneca vaccine
东方巴黎
知名会员
- 注册
- 2014-07-18
- 消息
- 2,770
- 荣誉分数
- 6
- 声望点数
- 148
义心…
